Literature DB >> 21368824

Copy number variation and selection during reprogramming to pluripotency.

Samer M Hussein1, Nizar N Batada, Sanna Vuoristo, Reagan W Ching, Reija Autio, Elisa Närvä, Siemon Ng, Michel Sourour, Riikka Hämäläinen, Cia Olsson, Karolina Lundin, Milla Mikkola, Ras Trokovic, Michael Peitz, Oliver Brüstle, David P Bazett-Jones, Kari Alitalo, Riitta Lahesmaa, Andras Nagy, Timo Otonkoski.   

Abstract

The mechanisms underlying the low efficiency of reprogramming somatic cells into induced pluripotent stem (iPS) cells are poorly understood. There is a clear need to study whether the reprogramming process itself compromises genomic integrity and, through this, the efficiency of iPS cell establishment. Using a high-resolution single nucleotide polymorphism array, we compared copy number variations (CNVs) of different passages of human iPS cells with their fibroblast cell origins and with human embryonic stem (ES) cells. Here we show that significantly more CNVs are present in early-passage human iPS cells than intermediate passage human iPS cells, fibroblasts or human ES cells. Most CNVs are formed de novo and generate genetic mosaicism in early-passage human iPS cells. Most of these novel CNVs rendered the affected cells at a selective disadvantage. Remarkably, expansion of human iPS cells in culture selects rapidly against mutated cells, driving the lines towards a genetic state resembling human ES cells.

Entities:  

Mesh:

Year:  2011        PMID: 21368824     DOI: 10.1038/nature09871

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  49 in total

1.  Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.

Authors:  Gary K Scott; Andrei Goga; Dipa Bhaumik; Crystal E Berger; Christopher S Sullivan; Christopher C Benz
Journal:  J Biol Chem       Date:  2006-11-16       Impact factor: 5.157

2.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

3.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

4.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.

Authors:  Vassilis G Gorgoulis; Leandros-Vassilios F Vassiliou; Panagiotis Karakaidos; Panayotis Zacharatos; Athanassios Kotsinas; Triantafillos Liloglou; Monica Venere; Richard A Ditullio; Nikolaos G Kastrinakis; Brynn Levy; Dimitris Kletsas; Akihiro Yoneta; Meenhard Herlyn; Christos Kittas; Thanos D Halazonetis
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

5.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

6.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

7.  Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants.

Authors:  Martin F Arlt; Jennifer G Mulle; Valerie M Schaibley; Ryan L Ragland; Sandra G Durkin; Stephen T Warren; Thomas W Glover
Journal:  Am J Hum Genet       Date:  2009-02-19       Impact factor: 11.025

8.  Effect of telomere proximity on telomere position effect, chromosome healing, and sensitivity to DNA double-strand breaks in a human tumor cell line.

Authors:  Avanti Kulkarni; Oliver Zschenker; Gloria Reynolds; Douglas Miller; John P Murnane
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

9.  Replication stress induces tumor-like microdeletions in FHIT/FRA3B.

Authors:  Sandra G Durkin; Ryan L Ragland; Martin F Arlt; Jennifer G Mulle; Stephen T Warren; Thomas W Glover
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-27       Impact factor: 11.205

10.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.

Authors:  Knut Woltjen; Iacovos P Michael; Paria Mohseni; Ridham Desai; Maria Mileikovsky; Riikka Hämäläinen; Rebecca Cowling; Wei Wang; Pentao Liu; Marina Gertsenstein; Keisuke Kaji; Hoon-Ki Sung; Andras Nagy
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

View more
  420 in total

1.  Generation of induced pluripotent stem cells from urine.

Authors:  Ting Zhou; Christina Benda; Sarah Duzinger; Yinghua Huang; Xingyan Li; Yanhua Li; Xiangpeng Guo; Guokun Cao; Shen Chen; Lili Hao; Yau-Chi Chan; Kwong-Man Ng; Jenny Cy Ho; Matthias Wieser; Jiayan Wu; Heinz Redl; Hung-Fat Tse; Johannes Grillari; Regina Grillari-Voglauer; Duanqing Pei; Miguel A Esteban
Journal:  J Am Soc Nephrol       Date:  2011-06-02       Impact factor: 10.121

Review 2.  Cellular reprogramming: recent advances in modeling neurological diseases.

Authors:  Guo-Li Ming; Oliver Brüstle; Alysson Muotri; Lorenz Studer; Marius Wernig; Kimberly M Christian
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 3.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

4.  Building stem-cell genomics in California and beyond.

Authors:  Natalie D Dewitt; Michael P Yaffe; Alan Trounson
Journal:  Nat Biotechnol       Date:  2012-01-09       Impact factor: 54.908

5.  Are embryonic stem and induced pluripotent stem cells the same or different? Implications for their potential therapeutic use.

Authors:  Constantina Christodoulou; Darrell N Kotton
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

Review 6.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

7.  The labyrinth of nuclear reprogramming.

Authors:  Ignacio Sancho-Martinez; Emmanuel Nivet; Juan Carlos Izpisua Belmonte
Journal:  J Mol Cell Biol       Date:  2011-11-16       Impact factor: 6.216

Review 8.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 9.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

10.  Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.

Authors:  Lauren V Schnabel; Christian M Abratte; John C Schimenti; M Julia Bevilaqua Felippe; Jennifer M Cassano; Teresa L Southard; Jessica A Cross; Lisa A Fortier
Journal:  Regen Med       Date:  2014-04-28       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.